Page last updated: 2024-10-27

fluorouracil and Infections, Respiratory Syncytial Virus

fluorouracil has been researched along with Infections, Respiratory Syncytial Virus in 3 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, KH1
Crowe, JE3
Lubeck, MD1
Davis, AR2
Hung, PP1
Chanock, RM2
Murphy, BR3
Bui, PT1
Karron, RA1
Wright, PF1
Clements-Mann, ML1
Thompson, J1
Makhene, M1
Casey, R1

Trials

1 trial available for fluorouracil and Infections, Respiratory Syncytial Virus

ArticleYear
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
    The Journal of infectious diseases, 1997, Volume: 176, Issue:6

    Topics: Adolescent; Adult; Animals; Antibodies, Viral; Cell Line; Child, Preschool; Double-Blind Method; Fem

1997

Other Studies

2 other studies available for fluorouracil and Infections, Respiratory Syncytial Virus

ArticleYear
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.
    Vaccine, 1995, Volume: 13, Issue:5

    Topics: Animals; Azacitidine; Carcinoma, Squamous Cell; Chlorocebus aethiops; Female; Fluorouracil; Male; Mi

1995
A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.
    Vaccine, 1994, Volume: 12, Issue:9

    Topics: Animals; Cattle; Cell Line, Transformed; Chlorocebus aethiops; Cold Temperature; Culture Techniques;

1994